Eton Pharmaceuticals (ETON) Payables: 2019-2025
Historic Payables for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $14.3 million.
- Eton Pharmaceuticals' Payables rose 431.26% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.4 million, marking a year-over-year increase of 296.95%. This contributed to the annual value of $4.2 million for FY2024, which is 125.49% up from last year.
- Per Eton Pharmaceuticals' latest filing, its Payables stood at $14.3 million for Q3 2025, which was up 17.44% from $12.1 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Payables high stood at $14.3 million for Q3 2025, and its period low was $1.1 million during Q3 2022.
- For the 3-year period, Eton Pharmaceuticals' Payables averaged around $4.5 million, with its median value being $2.3 million (2023).
- Its Payables has fluctuated over the past 5 years, first crashed by 67.80% in 2022, then surged by 469.25% in 2025.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Payables stood at $1.8 million in 2021, then dropped by 0.45% to $1.8 million in 2022, then increased by 4.64% to $1.8 million in 2023, then skyrocketed by 125.49% to $4.2 million in 2024, then skyrocketed by 431.26% to $14.3 million in 2025.
- Its Payables was $14.3 million in Q3 2025, compared to $12.1 million in Q2 2025 and $4.9 million in Q1 2025.